» Articles » PMID: 29187894

Material-induced Senescence (MIS): Fluidity Induces Senescent Type Cell Death of Lung Cancer Cells Via Insulin-Like Growth Factor Binding Protein 5

Overview
Journal Theranostics
Date 2017 Dec 1
PMID 29187894
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We propose here material-induced senescence (MIS) as a new therapeutic concept that limits cancer progression by stable cell cycle arrest. This study examined for the first time the effect of material fluidity on cellular senescence in lung carcinoma using poly(ε-caprolactone--D, L-lactide) (P(CL--DLLA)) with tunable elasticity and fluidity. The fluidity was varied by chemically crosslinking the polymer networks: the crosslinked P(CL--DLLA) shows solid-like properties with a stiffness of 260 kPa, while the non-crosslinked polymer exists in a quasi-liquid state with loss and storage moduli of 33 kPa and 11 kPa, respectively. We found that cancer cells growing on the non-crosslinked, fluidic substrate undergo a non-apoptotic form of cell death and the cell cycle was accumulated in a G0/G1 phase. Next, we investigated the expression of biomarkers that are associated with cancer pathways. The cancer cells on the fluidic substrate expressed several biomarkers associated with senescence such as insulin-like growth factor binding protein 5 (IGFBP5). This result indicates that when cancer cells sense fluidity in their surroundings, the cells express IGFBP5, which in turn triggers the expression of tumor suppressor protein 53 and initiates cell cycle arrest at the G1 phase followed by cellular senescence. Furthermore, the cancer cells on the fluidic substrate maintained their epithelial phenotype, suggesting that the cancer cells do not undergo epithelial to mesenchymal transition. By considering these results as the fundamental information for MIS, our system could be applied to induce senescence in treatment-resistant cancers such as metastatic cancer or cancer stem cells.

Citing Articles

Signaling Pathways of the Insulin-like Growth Factor Binding Proteins.

Baxter R Endocr Rev. 2023; 44(5):753-778.

PMID: 36974712 PMC: 10502586. DOI: 10.1210/endrev/bnad008.


Viscoelastic Liquid Matrix with Faster Bulk Relaxation Time Reinforces the Cell Cycle Arrest Induction of the Breast Cancer Cells via Oxidative Stress.

Najmina M, Ebara M, Ohmura T, Uto K Int J Mol Sci. 2022; 23(23).

PMID: 36498966 PMC: 9736955. DOI: 10.3390/ijms232314637.


Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting.

Al-Azab M, Safi M, Idiiatullina E, Al-Shaebi F, Zaky M Cell Mol Biol Lett. 2022; 27(1):69.

PMID: 35986247 PMC: 9388978. DOI: 10.1186/s11658-022-00366-0.


Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.

Sun Y, Xiao Z, Chen Y, Xu D, Chen S Front Cell Dev Biol. 2022; 9:822465.

PMID: 35178407 PMC: 8844202. DOI: 10.3389/fcell.2021.822465.


Fluidity of Poly (ε-Caprolactone)-Based Material Induces Epithelial-to-Mesenchymal Transition.

Mano S, Uto K, Ebara M Int J Mol Sci. 2020; 21(5).

PMID: 32143443 PMC: 7084864. DOI: 10.3390/ijms21051757.


References
1.
Kim K, Seu Y, Baek S, Kim M, Kim K, Kim J . Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell. 2007; 18(11):4543-52. PMC: 2043568. DOI: 10.1091/mbc.e07-03-0280. View

2.
Sharpless N, DePinho R . Telomeres, stem cells, senescence, and cancer. J Clin Invest. 2004; 113(2):160-8. PMC: 311439. DOI: 10.1172/JCI20761. View

3.
Koohestani F, Braundmeier A, Mahdian A, Seo J, Bi J, Nowak R . Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells. PLoS One. 2013; 8(9):e75844. PMC: 3770620. DOI: 10.1371/journal.pone.0075844. View

4.
Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S . Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity. Biochem Biophys Res Commun. 2003; 310(2):612-8. DOI: 10.1016/j.bbrc.2003.09.058. View

5.
Carlos Acosta J, Gil J . Senescence: a new weapon for cancer therapy. Trends Cell Biol. 2012; 22(4):211-9. DOI: 10.1016/j.tcb.2011.11.006. View